APMD Apnimed, Inc.
$18.95▼ -0.21%
Healthcare
Other
Volume 178.5K
Avg Volume (10D) 336.8K
Key Metrics & Fundamentals
Market Cap
$788.90M
P/E Ratio
2.6
Div Yield
0.00%
52W Range
16.12 - 35.29
% vs 50 MA
-20.99%
% vs 200 MA
–%
RSI-14
43.8
MACD Histogram
+0.3500
Beta (1Y vs SPY)
0.56
Free Cash Flow
-$18.45M
Gross Rev
$12.08M
Gross Profit
$10.87M
EBITDA
-$97.08M
COGS
$1.21M
Operating Exp
$22.57M
Operating Income
-$11.70M
EBIT
-$11.70M
Pretax Income
$126.11M
Net Income
$125.94M
EPS (Diluted)
3.16
Price & Volume History
Loading chart…
Recent News
What iShares Russell 2000 Index Fund (IWM) Bought: APNIMED Leads on Oct. 15
GuruFocus.com · Oct 19, 2026 7:03 AM ET

iOnctura appoints Paul Sekhri as Chair of its Board of Directors
GlobeNewswire · Oct 15, 2026 3:30 AM ET

Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
GlobeNewswire · Oct 12, 2026 4:05 PM ET

Bank of America Puts These 2 Under-the-Radar IPO Stocks on Its Buy List
TipRanks · Oct 6, 2026 1:58 PM ET

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 2, 2026 4:05 PM ET

Was Moderna Stock's Cancer Vaccine Run Visible In Advance?
Trefis · Sep 22, 2026 1:39 PM ET
Apnimed Q2 Swings to Earnings, Revenue Declines
MT Newswires · Sep 8, 2026 4:52 PM ET

Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Sep 8, 2026 4:39 PM ET

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 4, 2026 4:01 PM ET

BofA makes bullish call on newly public biotech stock
TheStreet · Aug 28, 2026 9:03 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See APMD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.